Tensions rise in the US after a fatal shooting by an immigration officer. UK forces assist in seizing a tanker linked to Russia, Iran & Venezuela. New weight loss injection research reveals a surprising risk. Get the full story.
New research shows weight and heart health markers deteriorate after ending GLP-1 drug use, raising questions about long-term treatment for obesity in the UK.
Financial News explores the major themes set to shape the UK wealth management sector in 2026, including consolidation, regulation, and cryptocurrency. Read our in-depth analysis.
New research indicates weight loss drugs Mounjaro and Wegovy might require lifelong use to maintain results, as patients rapidly regain weight after stopping. Nearly 2 million UK adults have used the jabs.
New research from the University of Oxford shows people regain weight four times faster after stopping GLP-1 drugs than with behavioural plans. Discover the long-term implications.
Michelin-starred chef Tommy Banks reveals to Sky News the 'political decisions' crippling UK hospitality, the impact of weight loss drugs, and why your cooking needs more salt. Read his full interview.
Discover the nine key financial strategies used by society's richest, from investing over saving to building multiple income streams. Learn how to adopt a wealth mindset today.
The Berne Financial Services Agreement, effective 1 Jan 2026, is a major post-Brexit deal. It boosts UK-Swiss finance via mutual recognition, cutting costs and fostering growth. Discover the details.
An ITV probe exposes how people with healthy BMIs use photo-editing software to obtain Mounjaro prescriptions online. Experts warn this fuels disordered eating and demands urgent safeguards.
The UK has avoided the OECD's PISA financial literacy test since 2012. As the government explores joining in 2029, experts argue participation is vital for evidence-based policy, productivity, and inclusion.
A new Channel 5 poll uncovers surprising British attitudes on family, finance, and personal freedom. Discover the results on paying grandparents, weight-loss jabs, and inheritance.
For women over 40, stubborn weight gain is often due to hormonal changes affecting metabolism, not diet failure. Discover why the 'calories in, calories out' model fails and what to do.
Novo Nordisk launches the first GLP-1 weight-loss pill in the US, priced significantly lower than injectable versions, intensifying competition with Eli Lilly.
Paul Daley reflects on the profound grief and enduring lessons from his late Labrador, Ronda, whose patience and gentle nature left an indelible mark on his family and another dog, Olive. Discover how pets shape our lives.
Nissan's UK arm reports a pre-tax loss of £888m, driven by an impairment charge and falling sales. A £990m capital injection aims to stabilise its balance sheet. Read the full analysis.
Struggling to lose weight after 40 despite no diet change? Experts say shifting hormones, not just calories, are key. Discover the science and a potential natural solution.
Policy Chairman Chris Hayward outlines how London will move from post-Brexit planning to execution in 2026, focusing on financial services, trade, and regulatory reform to secure its global status.
A 55-year-old man lost 20% body weight on Wegovy, reporting a surprising side effect: enhanced size and sexual performance dubbed 'Ozempic penis'. Read his full story.
The Financial Conduct Authority concludes its investigation into private equity-backed advice firms without enforcement action. Discover the details and regulatory implications.
Aisling McCarthy, dubbed her doctor's 'Ozempic poster girl', shares her transformative journey from chronic pain to health, and the crucial step most overlook when stopping the medication.
A seasoned social drinker shares his proven strategies for completing Dry January and extending it to three months, detailing the health benefits including significant weight loss and lower blood pressure. Discover how to survive the toughest weeks.
Leading scientist Kevin Hall, after 21 years at the NIH, exposes diet and exercise myths in a new book. Discover the real science of weight loss and metabolism. Read the full interview.
From vanishing snow to dried-up trails, Guardian US readers reveal the deeply personal impacts of the climate crisis this year and their renewed commitment to protect our planet.
New research reveals a surge in Brits using ChatGPT for investment decisions, averaging £2,350 per user. Discover the risks and regulatory changes shaping this trend.
Marks & Spencer unveils a new Nutrient Dense range of 20 meals and snacks, designed to support nutritional needs for those on GLP-1 weight-loss medication. Available from January 5.
Marks & Spencer unveils a new 'Nutrient Dense' food range designed for people using weight loss jabs like Ozempic. The 20-item collection aims to combat nutrient deficiencies. Discover the products and rival supermarket plans.
An investigation into China's controversial military-style 'fat prisons', where intense workouts and strict regimes promise rapid weight loss but raise serious safety concerns. Discover the stories behind the trend.
Marks & Spencer launches a new 'nutrient dense' food range on 5 January, targeting customers using appetite-suppressing GLP-1 medications like Wegovy. Discover the retail shift.
The UK's medicines regulator has seized £250,000 of unlicensed weight-loss drugs in a Northampton raid. Experts warn against buying jabs from social media due to serious health risks from counterfeits.
The National Trust's annual audit reveals how heat, drought, and wildfires have severely damaged UK habitats and wildlife in 2025, with experts warning these are alarm signals we cannot ignore.